Nonvalvular atrial fibrillation and stroke: a review.
Nonvalvular atrial fibrillation accounts for more than thirty percent of all strokes above the age of sixty years. The use of anticoagulants for the primary prevention of stroke has been a controversial issue for a long time. New data has emerged which clarifies some of these issues and helps in selecting patients who are at a higher risk of stroke.
Khan
S A
SA
Department of Cardiology, West Middlesex University Hospital, Isleworth, U.K.
D000368:Aged; D000369:Aged, 80 and over; D000925:Anticoagulants / Q000008:administration & dosage / Q000009:adverse effects; D001281:Atrial Fibrillation / Q000150:complications* / Q000188:drug therapy / Q000209:etiology; D002561:Cerebrovascular Disorders / Q000209:etiology* / Q000517:prevention & control; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D012307:Risk Factors
D000925:Anticoagulants